350 related articles for article (PubMed ID: 8524802)
1. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.
Suzich JA; Ghim SJ; Palmer-Hill FJ; White WI; Tamura JK; Bell JA; Newsome JA; Jenson AB; Schlegel R
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11553-7. PubMed ID: 8524802
[TBL] [Abstract][Full Text] [Related]
2. Intraepithelial DNA immunisation with a plasmid encoding a codon optimised COPV E1 gene sequence, but not the wild-type gene sequence completely protects against mucosal challenge with infectious COPV in beagles.
Moore RA; Santos EB; Nicholls PK; White KL; Anderson DM; Lloyd A; Topley P; Romanos M; Thomsen L; Parmar V; Walcott S; Gough GW; Stanley MA
Virology; 2002 Dec; 304(2):451-9. PubMed ID: 12504584
[TBL] [Abstract][Full Text] [Related]
3. Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus.
Ghim S; Newsome J; Bell J; Sundberg JP; Schlegel R; Jenson AB
Exp Mol Pathol; 2000 Jun; 68(3):147-51. PubMed ID: 10816383
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection.
Nicholls PK; Klaunberg BA; Moore RA; Santos EB; Parry NR; Gough GW; Stanley MA
Virology; 1999 Dec; 265(2):365-74. PubMed ID: 10600607
[TBL] [Abstract][Full Text] [Related]
5. Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.
Yuan H; Estes PA; Chen Y; Newsome J; Olcese VA; Garcea RL; Schlegel R
J Virol; 2001 Sep; 75(17):7848-53. PubMed ID: 11483728
[TBL] [Abstract][Full Text] [Related]
6. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.
Kirnbauer R; Chandrachud LM; O'Neil BW; Wagner ER; Grindlay GJ; Armstrong A; McGarvie GM; Schiller JT; Lowy DR; Campo MS
Virology; 1996 May; 219(1):37-44. PubMed ID: 8623552
[TBL] [Abstract][Full Text] [Related]
7. Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs.
Stanley MA; Moore RA; Nicholls PK; Santos EB; Thomsen L; Parry N; Walcott S; Gough G
Vaccine; 2001 Apr; 19(20-22):2783-92. PubMed ID: 11282188
[TBL] [Abstract][Full Text] [Related]
8. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit.
Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581
[TBL] [Abstract][Full Text] [Related]
9. Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes.
Johnston KB; Monteiro JM; Schultz LD; Chen L; Wang F; Ausensi VA; Dell EC; Santos EB; Moore RA; Palker TJ; Stanley MA; Jansen KU
Virology; 2005 Jun; 336(2):208-18. PubMed ID: 15892962
[TBL] [Abstract][Full Text] [Related]
10. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes.
Chen Y; Ghim SJ; Jenson AB; Schlegel R
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2137-46. PubMed ID: 9747722
[TBL] [Abstract][Full Text] [Related]
11. Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes.
Nicholls PK; Moore PF; Anderson DM; Moore RA; Parry NR; Gough GW; Stanley MA
Virology; 2001 Apr; 283(1):31-9. PubMed ID: 11312659
[TBL] [Abstract][Full Text] [Related]
12. A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model.
Bell JA; Sundberg JP; Ghim SJ; Newsome J; Jenson AB; Schlegel R
Pathobiology; 1994; 62(4):194-8. PubMed ID: 7734063
[TBL] [Abstract][Full Text] [Related]
13. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic immunisation with COPV early genes by epithelial DNA delivery.
Moore RA; Walcott S; White KL; Anderson DM; Jain S; Lloyd A; Topley P; Thomsen L; Gough GW; Stanley MA
Virology; 2003 Sep; 314(2):630-5. PubMed ID: 14554090
[TBL] [Abstract][Full Text] [Related]
15. Cell-mediated immune responses to COPV early proteins.
Jain S; Moore RA; Anderson DM; Gough GW; Stanley MA
Virology; 2006 Dec 5-20; 356(1-2):23-34. PubMed ID: 16949120
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice.
Nardelli-Haefliger D; Roden RB; Benyacoub J; Sahli R; Kraehenbuhl JP; Schiller JT; Lachat P; Potts A; De Grandi P
Infect Immun; 1997 Aug; 65(8):3328-36. PubMed ID: 9234794
[TBL] [Abstract][Full Text] [Related]
17. Protection against papillomavirus with a polynucleotide vaccine.
Donnelly JJ; Martinez D; Jansen KU; Ellis RW; Montgomery DL; Liu MA
J Infect Dis; 1996 Feb; 173(2):314-20. PubMed ID: 8568291
[TBL] [Abstract][Full Text] [Related]
18. Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination.
Hines JF; Ghim SJ; Christensen ND; Kreider JW; Barnes WA; Schlegel R; Jenson AB
Gynecol Oncol; 1994 Oct; 55(1):13-20. PubMed ID: 7525426
[TBL] [Abstract][Full Text] [Related]
19. Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product.
Lin YL; Borenstein LA; Ahmed R; Wettstein FO
J Virol; 1993 Jul; 67(7):4154-62. PubMed ID: 7685411
[TBL] [Abstract][Full Text] [Related]
20. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
Park JS; Oh YK; Kang MJ; Kim CK
J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
